EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2

Qing Wen, Maohua Huang, Jingwen Xie, Runyu Liu, Qun Miao, Jinjun Huang, Junqiu Zhang, Wenyu Lyu, Ming Qi, Chunyi Wu, Qi Qi, Zhijing Zhang und 6 weitere

Drug Resistance Updates · 2023-07 · 69 · 100975

DOI: 10.1016/j.drup.2023.100975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2023-07. Verfasst von Qing Wen und 17 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jinan University, Guangzhou 510632, China. Hauptthemen laut MEDLINE: Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsRNA, Long NoncodingHumansAlanineCarrier ProteinsCell Line, TumorCysteineIn Situ Hybridization, FluorescenceMembrane ProteinsMembrane Transport ProteinsSerineMinor Histocompatibility AntigensAmino Acid Transport System ASC

Stichwörter der Autor:innen

ASCT2Antiangiogenic therapy resistanceAutophagic degradationLncRNASYTL5-OT4Vessel co-option

Substanzen

AlanineCarrier ProteinsCysteineMembrane ProteinsMembrane Transport ProteinsRNA, Long NoncodingSerineSYTL5 protein, humanSLC1A5 protein, humanMinor Histocompatibility Antigens

Autor:innen und Institutionen

  • College of Pharmacy, Jinan University, Guangzhou 510632, China.
  • School of Medicine, Jinan University, Guangzhou 510632, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Gua…
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Institute for Biotechnology, St. John's University, NY 11439, USA. Electronic address: chenz@stjohns.edu.
  • College of Pharmacy, Jinan University, Guangzhou 510632, China; Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University, Guangzhou 510632, China. Electronic addr…
  • College of Pharmacy, Jinan University, Guangzhou 510632, China. Electronic address: minfengchen@jnu.edu.cn.

Zitieren

APA

Wen, Q., Huang, M., Xie, J., Liu, R., Miao, Q., Huang, J., Zhang, J., Lyu, W., Qi, M., Wu, C., Qi, Q., Zhang, Z., Deng, R., Wang, C., Chen, Z. S., Zhang, D., Ye, W., & Chen, M. (2023). lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2. Drug Resistance Updates, 69, 100975. https://doi.org/10.1016/j.drup.2023.100975

Vancouver

Wen Q, Huang M, Xie J, Liu R, Miao Q, Huang J, et al. lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2. Drug Resistance Updates. 2023;69:100975. doi:10.1016/j.drup.2023.100975

BibTeX
@article{Wen2023,
  author = {Wen, Qing and Huang, Maohua and Xie, Jingwen and Liu, Runyu and Miao, Qun and Huang, Jinjun and Zhang, Junqiu and Lyu, Wenyu and Qi, Ming and Wu, Chunyi and Qi, Qi and Zhang, Zhijing and Deng, Rong and Wang, Chenran and Chen, Zhe-Sheng and Zhang, Dongmei and Ye, Wencai and Chen, Minfeng},
  title = {lncRNA SYTL5-OT4 promotes vessel co-option by inhibiting the autophagic degradation of ASCT2},
  journal = {Drug Resistance Updates},
  year = {2023},
  volume = {69},
  pages = {100975},
  doi = {10.1016/j.drup.2023.100975}
}
Kostenlos starten →